"REAL WORLD" DATA FROM PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA WHO HAVE BEEN TREATED WITH LENALIDOMIDE AND DEXAMETHASONE, ACCORDING TO THE STANDARD CLINICAL PRACTICE

被引：0

作者：

Katodritou, E. ^{[1
]}

Anagnostopoulos, A. ^{[2
]}

Vadikolia, C. ^{[2
]}

Lalayianni, C. ^{[2
]}

Kotsopoulou, M. ^{[3
]}

Repousis, P. ^{[3
]}

Megalakaki, A. ^{[3
]}

Rekleiti, A. ^{[3
]}

Dadakaridou, M. ^{[3
]}

Papageorgiou, G. ^{[3
]}

Kyrtsonis, M. ^{[4
]}

Matsouka, P. ^{[5
]}

Giannakoulas, N. ^{[5
]}

Kyriakou, D. ^{[5
]}

Karras, G. ^{[5
]}

Anagnostopoulos, N. ^{[6
]}

Michalis, E. ^{[6
]}

Briasoulis, E. ^{[7
]}

Hatzimichael, E. ^{[7
]}

Spanoudakis, E. ^{[8
]}

Zikos, P. ^{[9
]}

Tsakiridou, A. ^{[9
]}

Tsionos, K. ^{[10
]}

Anargyrou, K. ^{[11
]}

Symeonidis, A. ^{[12
]}

Maniati, A. ^{[13
]}

Terpos, E. ^{[14
]}

机构：

[1] Theagen Canc Hosp, Dept Hematol, Thessaloniki, Greece

[2] George Papanikolaou Gen Hosp, Hematol Dept, Thessaloniki, Greece

[3] Gen Anticancer Hosp Metaxa, Hematol Dept, Athens, Greece

[4] Gen Hosp Athens Laiko, Hematol Dept, Athens, Greece

[5] Univ Gen Hosp Larissa, Hematol Dept, Larisa, Greece

[6] Gen Hosp Athens G Gennimatas, Hematol Dept, Athens, Greece

[7] Univ Gen Hosp Ioannina, Hematol Dept, Ioannina, Greece

[8] Univ Gen Hosp Alexandroupolis, Hematol Dept, Alexandroupolis, Greece

[9] Gen Hosp Patras Agios Andreas, Hematol Dept, Patras, Greece

[10] Gen Airforce Hosp 251, Hematol Dept, Athens, Greece

[11] 251 Gen Airforce Hosp, Dept Hematol, Athens, Greece

[12] Univ Patras, Sch Med, Hematol Div, Patras, Greece

[13] Hosp Errikos Ntynan, Hematol Dept, Athens, Greece

[14] Univ Athens, Sch Med, Dept Clin Therapeut, Athens, Greece

来源：

HAEMATOLOGICA | 2013年 / 98卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

B1512

引用

页码：604 / 604

页数：1

共 50 条

[1] "Real-world" data on the efficacy and safety of lenalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma who were treated according to the standard clinical practice: a study of the Greek Myeloma Study Group
Katodritou, Eirini
Vadikolia, Chrysanthi
Lalagianni, Chrysavgi
Kotsopoulou, Maria
Papageorgiou, Georgia
Kyrtsonis, Marie-Christine
Matsouka, Panagiota
Giannakoulas, Nikolaos
Kyriakou, Despoina
Karras, Georgios
Anagnostopoulos, Nikolaos
Michali, Evridiki
Briasoulis, Evangelos
Hatzimichael, Eleftheria
Spanoudakis, Emmanouil
Zikos, Panagiotis
Tsakiridou, Anastasia
Tsionos, Konstantinos
Anargyrou, Konstantinos
Symeonidis, Argiris
Maniatis, Alice
Terpos, Evangelos
[J]. ANNALS OF HEMATOLOGY, 2014, 93 (01) : 129 - 139
[2] “Real-world” data on the efficacy and safety of lenalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma who were treated according to the standard clinical practice: a study of the Greek Myeloma Study Group
Eirini Katodritou
Chrysanthi Vadikolia
Chrysavgi Lalagianni
Maria Kotsopoulou
Georgia Papageorgiou
Marie-Christine Kyrtsonis
Panagiota Matsouka
Nikolaos Giannakoulas
Despoina Kyriakou
Georgios Karras
Nikolaos Anagnostopoulos
Evridiki Michali
Evangelos Briasoulis
Eleftheria Hatzimichael
Emmanouil Spanoudakis
Panagiotis Zikos
Anastasia Tsakiridou
Konstantinos Tsionos
Konstantinos Anargyrou
Argiris Symeonidis
Alice Maniatis
Evangelos Terpos
[J]. Annals of Hematology, 2014, 93 : 129 - 139
[3] Ixazomib, lenalidomide, and dexamethasone combination in "real-world" clinical practice in patients with relapsed/refractory multiple myeloma
Sokol, Juraj
Guman, Tomas
Chudej, Juraj
Hlebaskova, Monika
Stecova, Natalia
Valekova, Lubica
Kucerikova, Monika
Stasko, Jan
[J]. ANNALS OF HEMATOLOGY, 2022, 101 (01) : 81 - 89
[4] Ixazomib, lenalidomide, and dexamethasone combination in “real-world” clinical practice in patients with relapsed/refractory multiple myeloma
Juraj Sokol
Tomas Guman
Juraj Chudej
Monika Hlebaskova
Natalia Stecova
Lubica Valekova
Monika Kucerikova
Jan Stasko
[J]. Annals of Hematology, 2022, 101 : 81 - 89
[5] REAL WORLD USE OF IXAZOMIB WITH LENALIDOMIDE AND DEXAMETHASONE FOR PATIENTS WITH RELAPSED AND RELAPSED REFRACTORY MULTIPLE MYELOMA
Ziff, M.
Cheesman, S.
Kyriakou, C.
Mehta, A.
Papanikolaou, X.
Rabin, N.
Wechalekar, A.
Yong, K.
Popat, R.
[J]. HAEMATOLOGICA, 2017, 102 : 786 - 787
[6] Treatment of relapsed/refractory multiple myeloma patients with lenalidomide/dexamethasone in routine clinical practice
Schwarzer, A.
Fruehauf, S.
Knigsmann, M.
Schnell, R.
Reeb, M.
Heits, F.
Tirier, C.
Prange-Krex, G.
Knauf, W.
Bachinger, A.
Weiligmann, C.
Hoppe, G.
Glasmacher, A.
Schmidt, B.
[J]. ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 291 - 291
[7] Daratumumab with lenalidomide and dexamethasone in relapsed or refractory multiple myeloma patients - real world evidence analysis
Stork, Martin
Spicka, Ivan
Radocha, Jakub
Minarik, Jiri
Jelinek, Tomas
Jungova, Alexandra
Pavlicek, Petr
Pospisilova, Lenka
Sedlak, Frantisek
Straub, Jan
Pika, Tomas
Knechtova, Zdenka
Fidrichova, Anna
Boichuk, Ivanna
Sevcikova, Sabina
Maisnar, Vladimir
Hajek, Roman
Pour, Ludek
[J]. ANNALS OF HEMATOLOGY, 2023, 102 (06) : 1501 - 1511
[8] Daratumumab with lenalidomide and dexamethasone in relapsed or refractory multiple myeloma patients – real world evidence analysis
Martin Stork
Ivan Spicka
Jakub Radocha
Jiri Minarik
Tomas Jelinek
Alexandra Jungova
Petr Pavlicek
Lenka Pospisilova
Frantisek Sedlak
Jan Straub
Tomas Pika
Zdenka Knechtova
Anna Fidrichova
Ivanna Boichuk
Sabina Sevcikova
Vladimir Maisnar
Roman Hajek
Ludek Pour
[J]. Annals of Hematology, 2023, 102 : 1501 - 1511
[9] Real-world comparison of Ixazomib, lenalidomide and dexamethasone vs lenalidomide and dexamethasone in relapsed and refractory multiple myeloma
Minarik, Jiri
Pika, Tomas
Radocha, Jakub
Jungova, Alexandra
Straub, Jan
Jelinek, Tomas
Pour, Ludek
Pavlicek, Petr
Mistrik, Martin
Brozova, Lucie
Krhovska, Petra
Machalkova, Katerina
Jindra, Pavel
Spicka, Ivan
Plonkova, Hana
Stork, Martin
Bacovsky, Jaroslav
Capkova, Lenka
Sykora, Michal
Kessler, Petr
Stejskal, Lukas
Heindorfer, Adriana
Ullrychova, Jana
Maisnar, Vladimir
Hajek, Roman
[J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : E271 - E272
[10] Practical recommendations on the management of cytopenias in patients with relapsed/refractory multiple myeloma who are treated with lenalidomide and dexamethasone
Palumbo, A.
Sonneveld, P.
Dimopoulos, M.
San Miguel, J.
Harousseau, J. L.
Attal, M.
Hussein, M.
Knop, S.
Ludwig, H.
von Lihenfeld-Toal, M.
[J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 96 - 97

← 1 2 3 4 5 →